Iteos Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

iTeos Therapeutics

11/11/2021 13:04

* Iteos Therapeutics Inc  ITOS.OQ  reported quarterly adjusted
earnings of $1.86​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for earnings of $4.95 per share.
* Revenue was $104.27 million​;  analysts expected $161.13
million. 
* Iteos Therapeutics Inc's reported EPS for the quarter was
$1.86​.
* The mean earnings estimate of analysts had risen by about 97%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Iteos Therapeutics Inc shares had risen by 9.0% this
quarter and lost 13.0% so far this year.
* The company reported quarterly net income of $69.64 million.
* Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $48.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 01:04 p.m.
 ​All figures in US dollars unless otherwise stated